What is the recommended treatment for a yeast urinary tract infection (UTI) caused by Candida species?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Yeast Urinary Tract Infections

Fluconazole 200 mg daily for 2 weeks is the first-line treatment for yeast UTIs caused by fluconazole-susceptible Candida species, while amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days or flucytosine 25 mg/kg four times daily for 7-10 days are recommended for fluconazole-resistant species. 1

Treatment Algorithm Based on Candida Species

For Fluconazole-Susceptible Candida Species:

  • First-line: Fluconazole 200 mg daily for 2 weeks 1
    • Alternative dosing: 200 mg loading dose followed by 100 mg daily for at least 4 days 2
  • Fluconazole achieves high urinary concentrations and is available in both oral and intravenous formulations 3, 4

For Fluconazole-Resistant Candida Species (e.g., C. glabrata):

  1. First option: Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
  2. Second option: Oral flucytosine 25 mg/kg 4 times daily for 7-10 days 1
  3. For pyelonephritis: Consider combination therapy with amphotericin B deoxycholate plus flucytosine 1

Important Considerations

Pharmacokinetics

  • Echinocandins (e.g., micafungin, caspofungin) achieve poor urinary concentrations and should not be used for uncomplicated fungal UTIs 1, 5
  • Newer azoles also fail to achieve adequate urine concentrations 5
  • Amphotericin B deoxycholate and flucytosine achieve excellent urinary concentrations 1

Monitoring and Adjustments

  • Amphotericin B deoxycholate may require dose adjustment based on renal function with close monitoring for nephrotoxicity 1
  • Flucytosine requires significant dose adjustment in renal impairment and drug level monitoring 1
  • Flucytosine should not be used as monotherapy due to risk of resistance development 1

Non-Pharmacological Interventions

  • Remove indwelling catheters if present (approximately 50% success rate in clearing candiduria) 1, 3
  • Address underlying conditions (e.g., diabetes, broad-spectrum antibiotics) 3, 5

Special Situations

Asymptomatic Candiduria

  • Treatment is generally not recommended unless the patient is:
    • Neutropenic
    • A very low-birth-weight infant
    • Undergoing urologic manipulation 1, 3

Complicated Infections

  • For fungal balls or abscesses: Aggressive surgical debridement plus systemic antifungal therapy 1
  • Consider local irrigation with amphotericin B (50 mg/L of sterile water) as an adjunct to systemic therapy for complicated cases 1

Follow-up

  • Continue treatment until symptoms resolve and urine cultures become negative 1
  • Obtain follow-up urine cultures to confirm eradication 1

Common Pitfalls to Avoid

  • Using echinocandins or newer azoles for uncomplicated fungal UTIs due to poor urinary concentrations 1, 5
  • Treating asymptomatic candiduria unnecessarily 1, 3
  • Failing to remove indwelling catheters or address underlying conditions 1
  • Using lipid formulations of amphotericin B for lower UTIs (inadequate urine concentrations) 1

References

Guideline

Management of Fungal Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fluconazole dose recommendation in urinary tract infection.

The Annals of pharmacotherapy, 2001

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Research

Candida urinary tract infections--treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.